References
Below is a selection of articles where our products and services has been used. Please click here to visit the google scholar page to explore more articles.
Sandén, C., Landberg, N., Peña-Martínez, P. et al. Aberrant expression of SLAMF6 constitutes a targetable immune escape mechanism in acute myeloid leukemia. Nat Cancer (2025).
https://doi.org/10.1038/s43018-025-01054-6
Jungholm, O., Trkulja, C., Moche, M. et al. Novel druggable space in human KRAS G13D discovered using structural bioinformatics and a P-loop targeting monoclonal antibody. Sci Rep 14, 19656 (2024).
https://doi.org/10.1038/s41598-024-70217-9
, , , et al. APOE Christchurch-mimetic therapeutic antibody reduces APOE-mediated toxicity and tau phosphorylation. Alzheimer’s Dement. 2024; 20: 819–836.
https://doi.org/10.1002/alz.13436
Nyesiga, B., Levin, M., Säll, A., Rosén, A., Jansson, K., Fritzell, S., … von Schantz, L. (2024). RUBY® – a tetravalent (2+2) bispecific antibody format with excellent functionality and IgG-like stability, pharmacology and developability properties. mAbs, 16(1).
https://doi.org/10.1080/19420862.2024.2330113
Ala-Nisula, T., Sah-Teli, S.K., Ronkainen, V.-P., Dimova, E.Y. and Koivunen, P. (2023), Human phytanoyl-CoA dioxygenase domain-containing 1 (PHYHD1) is a putative oxygen sensor associated with RNA and carbohydrate metabolism. FEBS Lett, 597: 1651-1666.
https://doi.org/10.1002/1873-3468.14666
Fields, James K. et al. Antibodies targeting the shared cytokine receptor IL-1 receptor accessory protein invoke distinct mechanisms to block all cytokine signaling. Cell Reports, Volume 43, Issue 5, 114099
DOI: 10.1016/j.celrep.2024.114099